Tadashi Ishida
0000-0001-9628-9125
Publication & Citation Trends
Most Cited Works
Publications
332 total
Impact of EGFR-TKI Treatment on the Tumor Immune Microenvironment in <i>EGFR</i> Mutation–Positive Non–Small Cell Lung Cancer
Cited by 238
OpenAlex
Efficacy and safety of nivolumab in previously treated patients with non-small cell lung cancer: A multicenter retrospective cohort study
Cited by 147
OpenAlex
Pseudoprogression in Previously Treated Patients with Non–Small Cell Lung Cancer Who Received Nivolumab Monotherapy
Cited by 117
OpenAlex
Tumor immune microenvironment and nivolumab efficacy in EGFR mutation-positive non-small-cell lung cancer based on T790M status after disease progression during EGFR-TKI treatment PDF
Cited by 293
OpenAlex
Spatiotemporal T790M Heterogeneity in Individual Patients with EGFR-Mutant Non–Small-Cell Lung Cancer after Acquired Resistance to EGFR-TKI PDF
Cited by 156
OpenAlex
The dynamics of herpesvirus reactivations during and after severe drug eruptions: their relation to the clinical phenotype and therapeutic outcome PDF
Cited by 107
OpenAlex
Rebiopsy of non–small cell lung cancer patients with acquired resistance to epidermal growth factor receptor‐tyrosine kinase inhibitor PDF
Cited by 178
OpenAlex
Research Topics
Pneumonia and Respiratory Infections
(92)
Lung Cancer Treatments and Mutations
(48)
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
(48)
Respiratory viral infections research
(38)
Pneumocystis jirovecii pneumonia detection and treatment
(36)
Frequent Co-Authors
Affiliations
Otsuka (Japan)
Fukushima Medical University
Kyorin University
Kyoto University
Saitama Prefecture